UNSPSC 51401508: Lormetazepam

This classification denotes a benzodiazepine with the molecular formula C16H12Cl2N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GU56C842ZA, chemically known as 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2h-1,4-benzodiazepin-2-one but generally known as lormetazepam, which bears US NIH Compound Identifier 13314. European Medicines Agency schedules Lormetazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08588MIG.

UNSPSC 51401508 Lormetazepam is a Commodity code that maps poorly to recent state and local procurement activity. The single recorded recent opportunity under this code—Seminole County, Florida's IFB for naloxone and drug deactivation systems—involves purchase of emergency opioid-reversal medication and harm-reduction equipment for community health programs, not lormetazepam (a benzodiazepine sedative used in clinical settings). The mismatch suggests either a classification error in the county's tagging or a data gap in the opportunities block, leaving insufficient evidence of what state and local governments actually procure under this Commodity code.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford, Florida. The IFB closed July 26, 2023, and required vendors to submit bids through the county's e-Procurement Portal with all shipping and delivery costs included in pricing. The initial contract term was two years with an optional one-year renewal. Beyond this single opportunity, the source provides no additional state or local solicitations, repeat-buyer patterns, or geographic spread to characterize the code's broader activity.